Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - DYNAVAX TECHNOLOGIES CORP | dvax-ex322_7.htm |
| EX-32.1 - EX-32.1 - DYNAVAX TECHNOLOGIES CORP | dvax-ex321_9.htm |
| EX-31.2 - EX-31.2 - DYNAVAX TECHNOLOGIES CORP | dvax-ex312_12.htm |
| EX-31.1 - EX-31.1 - DYNAVAX TECHNOLOGIES CORP | dvax-ex311_14.htm |
| EX-21.1 - EX-21.1 - DYNAVAX TECHNOLOGIES CORP | dvax-ex211_15.htm |
| EX-10.33 - EX-10.33 - DYNAVAX TECHNOLOGIES CORP | dvax-ex1033_133.htm |
| EX-10.32 - EX-10.32 - DYNAVAX TECHNOLOGIES CORP | dvax-ex1032_132.htm |
| EX-10.31 - EX-10.31 - DYNAVAX TECHNOLOGIES CORP | dvax-ex1031_356.htm |
| EX-4.1 - EX-4.1 - DYNAVAX TECHNOLOGIES CORP | dvax-ex41_11.htm |
| 10-K - 10-K - DYNAVAX TECHNOLOGIES CORP | dvax-10k_20201231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
|
(1) |
Registration Statement (Form S-3ASR Nos. 333-239663 and 333-241678) of Dynavax Technologies Corporation and in the related Prospectuses, and |
|
|
(2) |
Registration Statements (Form S-8 Nos. 333-211747, 333-221832, 333-225525, 333-218470, 333-204506, 333-197838, 333-190313, 333-171552, 333-233247 and 333-241674) pertaining to the Amended and Restated 2011 Equity Incentive Plan, the Amended and Restated 2014 Employee Stock Purchase Plan, the 2017 Inducement Award Plan, the 2018 Equity Incentive Plan and Amended and Restated 2018 Equity Incentive Plan of Dynavax Technologies Corporation; |
of our reports dated February 25, 2021, with respect to the consolidated financial statements of Dynavax Technologies Corporation and the effectiveness of internal control over financial reporting of Dynavax Technologies Corporation included in this Annual Report (Form 10-K) of Dynavax Technologies Corporation for the year ended December 31, 2020.
/s/ Ernst & Young LLP
San Francisco, California
February 25, 2021